Pharmaceutical administration practice during prevention and treatment of COVID-19

Abstract

January 25, 2020, our hospital was served as the designated hospital for critically ill patients with new coronary pneumonia in Wuhan. The timely and effective pharmaceutical emergency protection system was great significance for epidemic prevention. In order to ensure the drug demand of patients and improve the level of drug treatment, the key and difficult issues in the practice of administration during new coronary pneumonia were combined with clinical practical work to develop an appropriate pharmaceutical emergency support system. Our department launched the emergency response mechanism, such as established list of COVID-19 key therapeutic drugs, urgently purchased therapeutic drugs, reformed the processes of emergency pharmacy, established a donated drug management system, establish the COVID-19 pharmaceutical care team, and opened a cloud pharmacy to meet the drug needs of non COVID-19 chronic diseases patients. We also strengthened the management of personnel protection. The administration during new coronary pneumonia is a professional, comprehensive, complex and systematic emergency project that guarantees the safety of drug supply, medication and enables the treatment work to be carried out in an orderly manner. Key words: COVID-19; Pharmacy administration; Clinical safe medication; COVID-19 hospital